Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

4DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Zyil1, Zyil-1, Schembl22230951, (1e)-2-[(2r)-1,2-dimethyl-2-pyrrolidinyl]-n-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)amino]carbonyl]ethenesulfonamide, 2455519-86-3, Ethenesulfonamide, 2-[(2r)-1,2-dimethyl-2-pyrrolidinyl]-n-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)amino]carbonyl]-, (1e)-

Molecular Formula

C₂₁H₂₉N₃O₃S

Molecular Weight

403.5 g/mol

InChI Key

HAMGPBKPACGWND-ZOXUKVPXSA-N

FDA UNII

P9ZQS28F8C

1 2D Structure

Usnoflast

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

1-[(E)-2-[(2R)-1,2-dimethylpyrrolidin-2-yl]ethenyl]sulfonyl-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea

2.1.2 InChI

InChI=1S/C21H29N3O3S/c1-21(10-5-12-24(21)2)11-13-28(26,27)23-20(25)22-19-17-8-3-6-15(17)14-16-7-4-9-18(16)19/h11,13-14H,3-10,12H2,1-2H3,(H2,22,23,25)/b13-11+/t21-/m1/s1

2.1.3 InChI Key

HAMGPBKPACGWND-ZOXUKVPXSA-N

2.1.4 Canonical SMILES

CC1(CCCN1C)C=CS(=O)(=O)NC(=O)NC2=C3CCCC3=CC4=C2CCC4

2.1.5 Isomeric SMILES

C[C@@]1(CCCN1C)/C=C/S(=O)(=O)NC(=O)NC2=C3CCCC3=CC4=C2CCC4

2.2 Other Identifiers

2.2.1 UNII

P9ZQS28F8C

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Zyil-1

2. Zyil1

2.3.2 Depositor-Supplied Synonyms

1. Zyil1

2. Zyil-1

3. Schembl22230951

4. (1e)-2-[(2r)-1,2-dimethyl-2-pyrrolidinyl]-n-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)amino]carbonyl]ethenesulfonamide

5. 2455519-86-3

6. Ethenesulfonamide, 2-[(2r)-1,2-dimethyl-2-pyrrolidinyl]-n-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)amino]carbonyl]-, (1e)-

2.4 Create Date

2020-09-28

3 Chemical and Physical Properties

Molecular Formula	C₂₁H₂₉N₃O₃S
Molecular Weight	403.5 g/mol
XLogP3	3.6
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	4
Exact Mass	g/mol
Monoisotopic Mass	g/mol
Topological Polar Surface Area	86.9
Heavy Atom Count	28
Formal Charge	0
Complexity	712
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	1
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1